HIV drug resistance surveillance using pooled pyrosequencing
- PMID: 20174661
- PMCID: PMC2822863
- DOI: 10.1371/journal.pone.0009263
HIV drug resistance surveillance using pooled pyrosequencing
Abstract
Background: Surveillance for HIV transmitted drug resistance (TDR) is performed using HIV genotype results from individual specimens. Pyrosequencing, through its massive parallel sequencing ability, can analyze large numbers of specimens simultaneously. Instead of using pyrosequencing conventionally, to sequence a population of viruses within an individual, we interrogated a single combined pool of surveillance specimens to demonstrate that it is possible to determine TDR rates in HIV protease from a population of individuals.
Methodology/principal findings: The protease region from 96 treatment naïve, HIV+ serum specimens was genotyped using standard Sanger sequencing method. The 462 bp protease amplicons from these specimens were pooled in equimolar concentrations and re-sequenced using the GS FLX Titanium system. The nucleotide (NT) and amino acid (AA) differences from the reference sequence, along with TDR mutations, detected by each method were compared. In the protease sequence, there were 212 nucleotide and 81 AA differences found using conventional sequencing and 345 nucleotide and 168 AA differences using pyrosequencing. All nucleotide and amino acid polymorphisms found at frequencies >/=5% in pyrosequencing were detected using both methods with the rates of variation highly correlated. Using Sanger sequencing, two TDR mutations, M46L and I84V, were each detected as mixtures at a frequency of 1.04% (1/96). These same TDR mutations were detected by pyrosequencing with a prevalence of 0.29% and 0.34% respectively. Phylogenetic analysis established that the detected low frequency mutations arose from the same single specimens that were found to contain TDR mutations by Sanger sequencing. Multiple clinical protease DR mutations present at higher frequencies were concordantly identified using both methods.
Conclusions/significance: We show that pyrosequencing pooled surveillance specimens can cost-competitively detect protease TDR mutations when compared with conventional methods. With few modifications, the method described here can be used to determine population rates of TDR in both protease and reverse transcriptase. Furthermore, this pooled pyrosequencing technique may be generalizable to other infectious agents where a survey of DR rates is required.
Conflict of interest statement
Figures






Similar articles
-
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. PLoS Med. 2015. PMID: 25849352 Free PMC article.
-
Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.PLoS One. 2015 May 26;10(5):e0125699. doi: 10.1371/journal.pone.0125699. eCollection 2015. PLoS One. 2015. PMID: 26010948 Free PMC article.
-
HIV transmitted drug resistance in adult and pediatric populations in Panama.Rev Panam Salud Publica. 2011 Dec;30(6):649-56. doi: 10.1590/s1020-49892011001200025. Rev Panam Salud Publica. 2011. PMID: 22358417
-
Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature.AIDS Res Hum Retroviruses. 2012 Jul;28(7):667-74. doi: 10.1089/aid.2010.0355. Epub 2011 Sep 23. AIDS Res Hum Retroviruses. 2012. PMID: 21851324 Free PMC article. Review.
-
Rationale and uses of a public HIV drug-resistance database.J Infect Dis. 2006 Sep 15;194 Suppl 1(Suppl 1):S51-8. doi: 10.1086/505356. J Infect Dis. 2006. PMID: 16921473 Free PMC article. Review.
Cited by
-
Multipurpose instantaneous microarray detection of acute encephalitis causing viruses and their expression profiles.Curr Microbiol. 2012 Sep;65(3):290-303. doi: 10.1007/s00284-012-0154-z. Epub 2012 Jun 7. Curr Microbiol. 2012. PMID: 22674173 Free PMC article. Review.
-
The emergence of drug resistant HIV variants and novel anti-retroviral therapy.Asian Pac J Trop Biomed. 2013 Jul;3(7):515-22. doi: 10.1016/S2221-1691(13)60106-9. Asian Pac J Trop Biomed. 2013. PMID: 23835806 Free PMC article. Review.
-
Pyrosequencing dried blood spots reveals differences in HIV drug resistance between treatment naïve and experienced patients.PLoS One. 2013;8(2):e56170. doi: 10.1371/journal.pone.0056170. Epub 2013 Feb 7. PLoS One. 2013. PMID: 23409150 Free PMC article.
-
Mechanisms controlling virulence thresholds of mixed viral populations.J Virol. 2011 Oct;85(19):9778-88. doi: 10.1128/JVI.00355-11. Epub 2011 Jul 27. J Virol. 2011. PMID: 21795346 Free PMC article.
-
Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.World J Gastroenterol. 2013 Nov 7;19(41):6995-7023. doi: 10.3748/wjg.v19.i41.6995. World J Gastroenterol. 2013. PMID: 24222943 Free PMC article. Review.
References
-
- Bennett DE. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world. Curr Opin Infect Dis. 2006;19:607–614. - PubMed
-
- Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13(Suppl 2):1–13. - PubMed
-
- Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther. 2008;13(Suppl 2):37–48. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials